<?xml version='1.0' encoding='utf-8'?>
<document id="29974143"><sentence text="Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects."><entity charOffset="48-61" id="DDI-PubMed.29974143.s1.e0" text="nitroglycerin" /><entity charOffset="71-81" id="DDI-PubMed.29974143.s1.e1" text="sacubitril" /><entity charOffset="82-91" id="DDI-PubMed.29974143.s1.e2" text="valsartan" /><entity charOffset="93-99" id="DDI-PubMed.29974143.s1.e3" text="LCZ696" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e0" e2="DDI-PubMed.29974143.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e0" e2="DDI-PubMed.29974143.s1.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e0" e2="DDI-PubMed.29974143.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e0" e2="DDI-PubMed.29974143.s1.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e1" e2="DDI-PubMed.29974143.s1.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e1" e2="DDI-PubMed.29974143.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e1" e2="DDI-PubMed.29974143.s1.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e2" e2="DDI-PubMed.29974143.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s1.e2" e2="DDI-PubMed.29974143.s1.e3" /></sentence><sentence text="Sacubitril/valsartan (LCZ696) and nitroglycerin share the second messenger cGMP and lower blood pressure"><entity charOffset="0-10" id="DDI-PubMed.29974143.s2.e0" text="Sacubitril" /><entity charOffset="11-20" id="DDI-PubMed.29974143.s2.e1" text="valsartan" /><entity charOffset="22-28" id="DDI-PubMed.29974143.s2.e2" text="LCZ696" /><entity charOffset="34-47" id="DDI-PubMed.29974143.s2.e3" text="nitroglycerin" /><entity charOffset="75-79" id="DDI-PubMed.29974143.s2.e4" text="cGMP" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e0" e2="DDI-PubMed.29974143.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e0" e2="DDI-PubMed.29974143.s2.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e0" e2="DDI-PubMed.29974143.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e0" e2="DDI-PubMed.29974143.s2.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e0" e2="DDI-PubMed.29974143.s2.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e1" e2="DDI-PubMed.29974143.s2.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e1" e2="DDI-PubMed.29974143.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e1" e2="DDI-PubMed.29974143.s2.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e1" e2="DDI-PubMed.29974143.s2.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e2" e2="DDI-PubMed.29974143.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e2" e2="DDI-PubMed.29974143.s2.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e2" e2="DDI-PubMed.29974143.s2.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e3" e2="DDI-PubMed.29974143.s2.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s2.e3" e2="DDI-PubMed.29974143.s2.e4" /></sentence><sentence text=" Given the potential for co-administration of both drugs in patients with heart failure, this study was designed to investigate the potential for a pharmacodynamic drug interaction affecting blood pressure" /><sentence text="" /><sentence text="In this double-blind, placebo-controlled, randomised, crossover study, 40 healthy subjects received sacubitril/valsartan 200 mg bid (97/103 mg bid) or placebo for 5 days"><entity charOffset="100-110" id="DDI-PubMed.29974143.s5.e0" text="sacubitril" /><entity charOffset="111-120" id="DDI-PubMed.29974143.s5.e1" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.29974143.s5.e0" e2="DDI-PubMed.29974143.s5.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s5.e0" e2="DDI-PubMed.29974143.s5.e1" /></sentence><sentence text=" Two hours after the morning dose of sacubitril/valsartan or placebo on day 5, subjects received intravenous nitroglycerin infusion at increasing doses up to 40 μg/min or placebo"><entity charOffset="37-47" id="DDI-PubMed.29974143.s6.e0" text="sacubitril" /><entity charOffset="48-57" id="DDI-PubMed.29974143.s6.e1" text="valsartan" /><entity charOffset="109-122" id="DDI-PubMed.29974143.s6.e2" text="nitroglycerin" /><pair ddi="false" e1="DDI-PubMed.29974143.s6.e0" e2="DDI-PubMed.29974143.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s6.e0" e2="DDI-PubMed.29974143.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s6.e0" e2="DDI-PubMed.29974143.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s6.e1" e2="DDI-PubMed.29974143.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s6.e1" e2="DDI-PubMed.29974143.s6.e2" /></sentence><sentence text=" Serial measurements of blood pressure (BP), heart rate, biomarkers and sacubitril/valsartan pharmacokinetics were conducted"><entity charOffset="83-92" id="DDI-PubMed.29974143.s7.e0" text="valsartan" /></sentence><sentence text="" /><sentence text="Administration of nitroglycerin alone led to a dose- and time-dependent decrease in supine systolic BP (SBP) and diastolic BP (DBP) which was similar when nitroglycerin was co-administered with sacubitril/valsartan"><entity charOffset="18-31" id="DDI-PubMed.29974143.s9.e0" text="nitroglycerin" /><entity charOffset="155-168" id="DDI-PubMed.29974143.s9.e1" text="nitroglycerin" /><entity charOffset="194-204" id="DDI-PubMed.29974143.s9.e2" text="sacubitril" /><entity charOffset="205-214" id="DDI-PubMed.29974143.s9.e3" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e0" e2="DDI-PubMed.29974143.s9.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e0" e2="DDI-PubMed.29974143.s9.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e0" e2="DDI-PubMed.29974143.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e0" e2="DDI-PubMed.29974143.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e1" e2="DDI-PubMed.29974143.s9.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e1" e2="DDI-PubMed.29974143.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e1" e2="DDI-PubMed.29974143.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e2" e2="DDI-PubMed.29974143.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s9.e2" e2="DDI-PubMed.29974143.s9.e3" /></sentence><sentence text=" At the highest dose of nitroglycerin, the mean (95% CI) decrease from baseline of SBP/DBP was 19"><entity charOffset="24-37" id="DDI-PubMed.29974143.s10.e0" text="nitroglycerin" /></sentence><sentence text="54 (- 21" /><sentence text="99, - 17" /><sentence text="09)/12" /><sentence text="38 (- 13" /><sentence text="85, - 10" /><sentence text="92) mmHg for nitroglycerin alone compared to 22"><entity charOffset="13-26" id="DDI-PubMed.29974143.s16.e0" text="nitroglycerin" /></sentence><sentence text="63 (- 25" /><sentence text="06, - 20" /><sentence text="21)/12" /><sentence text="94 (- 14" /><sentence text="38, - 11" /><sentence text="49) mmHg when co-administered with sacubitril/valsartan"><entity charOffset="35-45" id="DDI-PubMed.29974143.s22.e0" text="sacubitril" /><entity charOffset="46-55" id="DDI-PubMed.29974143.s22.e1" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.29974143.s22.e0" e2="DDI-PubMed.29974143.s22.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s22.e0" e2="DDI-PubMed.29974143.s22.e1" /></sentence><sentence text=" Co-administration of sacubitril/valsartan and nitroglycerin did not result in further plasma cGMP increase compared to sacubitril/valsartan alone"><entity charOffset="22-32" id="DDI-PubMed.29974143.s23.e0" text="sacubitril" /><entity charOffset="33-42" id="DDI-PubMed.29974143.s23.e1" text="valsartan" /><entity charOffset="47-60" id="DDI-PubMed.29974143.s23.e2" text="nitroglycerin" /><entity charOffset="120-130" id="DDI-PubMed.29974143.s23.e3" text="sacubitril" /><entity charOffset="131-140" id="DDI-PubMed.29974143.s23.e4" text="valsartan" /><entity charOffset="94-102" id="DDI-PubMed.29974143.s23.e5" text="cGMP" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e0" e2="DDI-PubMed.29974143.s23.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e0" e2="DDI-PubMed.29974143.s23.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e0" e2="DDI-PubMed.29974143.s23.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e0" e2="DDI-PubMed.29974143.s23.e5" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e0" e2="DDI-PubMed.29974143.s23.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e0" e2="DDI-PubMed.29974143.s23.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e1" e2="DDI-PubMed.29974143.s23.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e1" e2="DDI-PubMed.29974143.s23.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e1" e2="DDI-PubMed.29974143.s23.e5" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e1" e2="DDI-PubMed.29974143.s23.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e1" e2="DDI-PubMed.29974143.s23.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e2" e2="DDI-PubMed.29974143.s23.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e2" e2="DDI-PubMed.29974143.s23.e5" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e2" e2="DDI-PubMed.29974143.s23.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e2" e2="DDI-PubMed.29974143.s23.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e5" e2="DDI-PubMed.29974143.s23.e5" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e5" e2="DDI-PubMed.29974143.s23.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e5" e2="DDI-PubMed.29974143.s23.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e3" e2="DDI-PubMed.29974143.s23.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s23.e3" e2="DDI-PubMed.29974143.s23.e4" /></sentence><sentence text=" The co-administration of nitroglycerin and sacubitril/valsartan was safe and well tolerated and did not impact the pharmacokinetics of sacubitril/valsartan"><entity charOffset="26-39" id="DDI-PubMed.29974143.s24.e0" text="nitroglycerin" /><entity charOffset="44-54" id="DDI-PubMed.29974143.s24.e1" text="sacubitril" /><entity charOffset="55-64" id="DDI-PubMed.29974143.s24.e2" text="valsartan" /><entity charOffset="136-146" id="DDI-PubMed.29974143.s24.e3" text="sacubitril" /><entity charOffset="147-156" id="DDI-PubMed.29974143.s24.e4" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e0" e2="DDI-PubMed.29974143.s24.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e0" e2="DDI-PubMed.29974143.s24.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e0" e2="DDI-PubMed.29974143.s24.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e0" e2="DDI-PubMed.29974143.s24.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e0" e2="DDI-PubMed.29974143.s24.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e1" e2="DDI-PubMed.29974143.s24.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e1" e2="DDI-PubMed.29974143.s24.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e1" e2="DDI-PubMed.29974143.s24.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e1" e2="DDI-PubMed.29974143.s24.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e2" e2="DDI-PubMed.29974143.s24.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e2" e2="DDI-PubMed.29974143.s24.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e2" e2="DDI-PubMed.29974143.s24.e4" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e3" e2="DDI-PubMed.29974143.s24.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s24.e3" e2="DDI-PubMed.29974143.s24.e4" /></sentence><sentence text="" /><sentence text="The results from this study demonstrate no pharmacodynamic drug interaction between nitroglycerin and sacubitril/valsartan in healthy subjects, suggesting that no change of dose selection and escalation recommendations or clinical monitoring during nitroglycerin administration is required"><entity charOffset="84-97" id="DDI-PubMed.29974143.s26.e0" text="nitroglycerin" /><entity charOffset="102-112" id="DDI-PubMed.29974143.s26.e1" text="sacubitril" /><entity charOffset="113-122" id="DDI-PubMed.29974143.s26.e2" text="valsartan" /><entity charOffset="249-262" id="DDI-PubMed.29974143.s26.e3" text="nitroglycerin" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e0" e2="DDI-PubMed.29974143.s26.e0" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e0" e2="DDI-PubMed.29974143.s26.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e0" e2="DDI-PubMed.29974143.s26.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e0" e2="DDI-PubMed.29974143.s26.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e1" e2="DDI-PubMed.29974143.s26.e1" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e1" e2="DDI-PubMed.29974143.s26.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e1" e2="DDI-PubMed.29974143.s26.e3" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e2" e2="DDI-PubMed.29974143.s26.e2" /><pair ddi="false" e1="DDI-PubMed.29974143.s26.e2" e2="DDI-PubMed.29974143.s26.e3" /></sentence><sentence text="" /></document>